{"id":"https://openalex.org/W7143513743","doi":"https://doi.org/10.1107/s2053273325099553","title":"Covalent fragment-based drug discovery as a strategy to combat leishmaniasis","display_name":"Covalent fragment-based drug discovery as a strategy to combat leishmaniasis","publication_year":2026,"publication_date":"2026-03-30","ids":{"openalex":"https://openalex.org/W7143513743","doi":"https://doi.org/10.1107/s2053273325099553"},"language":"en","primary_location":{"id":"doi:10.1107/s2053273325099553","doi":"https://doi.org/10.1107/s2053273325099553","is_oa":true,"landing_page_url":"https://doi.org/10.1107/s2053273325099553","pdf_url":"https://doi.org/10.1107/s2053273325099553","source":{"id":"https://openalex.org/S4393918093","display_name":"Acta Crystallographica Section A Foundations and Advances","issn_l":"2053-2733","issn":["2053-2733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-200","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Crystallographica Section A Foundations and Advances","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1107/s2053273325099553","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003299263","display_name":"Maria Cristina Nonato","orcid":"https://orcid.org/0000-0002-4916-1505","observed_orcids":["https://orcid.org/0000-0002-4916-1505"]},"institutions":[{"id":"https://openalex.org/I17974374","display_name":"Universidade de S\u00e3o Paulo","ror":"https://ror.org/036rp1748","country_code":"BR","type":"education","lineage":["https://openalex.org/I17974374"]}],"countries":["BR"],"is_corresponding":true,"raw_author_name":"Maria Cristina Nonato","raw_affiliation_strings":["Center for the Research and Advancement in Fragments and molecular Targets (CRAFT) , School of Pharmaceutical Sciences at Ribeirao Preto , University of S\u00e3o Paulo , Ribeir\u00e3o Preto 14040-903 , SP , Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for the Research and Advancement in Fragments and molecular Targets (CRAFT) , School of Pharmaceutical Sciences at Ribeirao Preto , University of S\u00e3o Paulo , Ribeir\u00e3o Preto 14040-903 , SP , Brazil","institution_ids":["https://openalex.org/I17974374"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5003299263"],"corresponding_institution_ids":["https://openalex.org/I17974374"],"apc_list":{"value":4430,"currency":"USD","value_usd":4430},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.19057578,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"81","issue":"a1","first_page":"e45","last_page":"e45"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.3418000042438507,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.3418000042438507,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.15719999372959137,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.10830000042915344,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covalent-inhibitors","display_name":"covalent inhibitors","score":0.9229999780654907},{"id":"https://openalex.org/keywords/leishmaniasis","display_name":"leishmaniasis","score":0.8840000033378601},{"id":"https://openalex.org/keywords/leishmania-braziliensis","display_name":"Leishmania braziliensis","score":0.9860000014305115},{"id":"https://openalex.org/keywords/dihydroorotate-dehydrogenase","display_name":"dihydroorotate dehydrogenase","score":0.9959999918937683},{"id":"https://openalex.org/keywords/barbiturates","display_name":"barbiturates","score":0.9449999928474426},{"id":"https://openalex.org/keywords/conjugated-dienes","display_name":"conjugated dienes","score":0.8640000224113464},{"id":"https://openalex.org/keywords/antiparasitic-drug-discovery","display_name":"antiparasitic drug discovery","score":0.8159999847412109}],"concepts":[{"id":"https://openalex.org/C2779865431","wikidata":"https://www.wikidata.org/wiki/Q1150909","display_name":"Dihydroorotate dehydrogenase","level":3,"score":0.7135000228881836},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.675000011920929},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6553000211715698},{"id":"https://openalex.org/C180577832","wikidata":"https://www.wikidata.org/wiki/Q127920","display_name":"Covalent bond","level":2,"score":0.5831000208854675},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4657999873161316},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.45509999990463257},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44279998540878296},{"id":"https://openalex.org/C2781092759","wikidata":"https://www.wikidata.org/wiki/Q524818","display_name":"Leishmania","level":3,"score":0.4115999937057495},{"id":"https://openalex.org/C2781421772","wikidata":"https://www.wikidata.org/wiki/Q581102","display_name":"Antiparasitic","level":2,"score":0.3725000023841858},{"id":"https://openalex.org/C2776555147","wikidata":"https://www.wikidata.org/wiki/Q331283","display_name":"Leishmaniasis","level":2,"score":0.3625999987125397},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.35519999265670776},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.32179999351501465},{"id":"https://openalex.org/C2989108626","wikidata":"https://www.wikidata.org/wiki/Q904407","display_name":"Drug target","level":2,"score":0.310699999332428},{"id":"https://openalex.org/C2777735729","wikidata":"https://www.wikidata.org/wiki/Q2493699","display_name":"Leishmania braziliensis","level":4,"score":0.3100000023841858},{"id":"https://openalex.org/C2911037157","wikidata":"https://www.wikidata.org/wiki/Q581102","display_name":"Antiparasitic agent","level":2,"score":0.3061999976634979},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.2944999933242798},{"id":"https://openalex.org/C171852809","wikidata":"https://www.wikidata.org/wiki/Q731154","display_name":"Chemical biology","level":2,"score":0.29089999198913574},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.2865999937057495},{"id":"https://openalex.org/C2779793070","wikidata":"https://www.wikidata.org/wiki/Q410278","display_name":"Barbituric acid","level":2,"score":0.28130000829696655}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1107/s2053273325099553","doi":"https://doi.org/10.1107/s2053273325099553","is_oa":true,"landing_page_url":"https://doi.org/10.1107/s2053273325099553","pdf_url":"https://doi.org/10.1107/s2053273325099553","source":{"id":"https://openalex.org/S4393918093","display_name":"Acta Crystallographica Section A Foundations and Advances","issn_l":"2053-2733","issn":["2053-2733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-200","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Crystallographica Section A Foundations and Advances","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1107/s2053273325099553","doi":"https://doi.org/10.1107/s2053273325099553","is_oa":true,"landing_page_url":"https://doi.org/10.1107/s2053273325099553","pdf_url":"https://doi.org/10.1107/s2053273325099553","source":{"id":"https://openalex.org/S4393918093","display_name":"Acta Crystallographica Section A Foundations and Advances","issn_l":"2053-2733","issn":["2053-2733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-200","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Crystallographica Section A Foundations and Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7143513743.pdf","grobid_xml":"https://content.openalex.org/works/W7143513743.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4412396939","https://openalex.org/W2098098358","https://openalex.org/W7120875075","https://openalex.org/W7172252223","https://openalex.org/W7055059965","https://openalex.org/W4200132653","https://openalex.org/W6980354222","https://openalex.org/W2097402736","https://openalex.org/W2330895648","https://openalex.org/W4417290943"],"abstract_inverted_index":{"Covalent":[0],"inhibition":[1],"has":[2],"emerged":[3],"as":[4,31,43],"a":[5,12,54,71],"powerful":[6],"strategy":[7],"in":[8],"drug":[9],"discovery,":[10],"offering":[11],"unique":[13],"combination":[14],"of":[15,37,46,57],"potency,":[16],"selectivity,":[17],"and":[18],"sustained":[19],"target":[20],"engagement.Building":[21],"on":[22],"our":[23],"previous":[24],"findings-where":[25],"we":[26],"identified":[27,68],"barbituric":[28],"acid":[29,60],"derivatives":[30],"orotate":[32],"bioisosteres":[33],"that,":[34],"upon":[35],"introduction":[36],"an":[38],"exocyclic":[39],"double":[40],"bond,":[41],"acted":[42],"covalent":[44],"inhibitors":[45],"Leishmania":[47],"braziliensis":[48],"dihydroorotate":[49],"dehydrogenase":[50],"(LbDHODH)-we":[51],"now":[52],"report":[53],"new":[55],"series":[56],"conjugated":[58],"dienebarbituric":[59],"compounds":[61],"derived":[62],"from":[63],"the":[64],"most":[65],"potent":[66],"previously":[67],"inhibitor,":[69],"2i,":[70],"nanomolar":[72],"compound":[73],"with":[74],"antiparasitic":[75],"activity.":[76]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-03-31T00:00:00"}